Parallel Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Parallel Advisors's ABMD Position: Q4 2022 in Review
Parallel Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 184 shares — an estimated $45K sold.
Parallel Advisors first reported a position in ABMD in Q2 2018 and held it in 16 quarters. The position peaked at $62K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Parallel Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Parallel Advisors sold 184 Abiomed Inc shares in Q4 2022, an estimated $45K.
- Parallel Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 16 quarters.
- Parallel Advisors's Abiomed Inc position peaked at $62K in Q1 2022.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.